| 摘要 |
The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering a proteasome inhibiting compound, and ///-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chl oro-4-(4-chloro-1 - methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide, or a pharmaceutically acceptable salt thereof, and optional additional antineoplastic agents, to a human in need thereof. |
